Literature DB >> 5942010

Therapeutic utilization of the diurnal variation in pituitary-adrenocortical activity.

E J Segre, E L Klaiber.   

Abstract

The degree of pituitary-adrenocortical suppression resulting from exogenous corticosteroid is related to the time of day the steroid is administered. Morning administration has less effect and evening administration a greater effect than do divided doses given over the course of the day. Clinical studies have shown that in the great majority of patients with corticosteroid responsive diseases, an intermittent dosage schedule is at least as effective as is administration of an equal dose in a three or four times a day regimen. Other undesirable side effects of corticosteroid therapy may also be decreased by an intermittent schedule. It is suggested that the customary divided dosage schedule for corticosteroid administration be replaced with an intermittent regimen, the medication being given in the morning. This may be once a day, or, if therapeutic results are satisfactory, once every other day.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5942010      PMCID: PMC1516217     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  9 in total

1.  A MODIFIED (ONCE A DAY) CORTICOSTEROID DOSAGE REGIMEN.

Authors:  C H DEMOS; F KRASNER; J T GROEL
Journal:  Clin Pharmacol Ther       Date:  1964 Nov-Dec       Impact factor: 6.875

2.  STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN.

Authors:  J G HARTER; W J REDDY; G W THORN
Journal:  N Engl J Med       Date:  1963-09-19       Impact factor: 91.245

3.  TEMPORAL VARIATION IN SU-4885 RESPONSIVENESS IN MAN: EVIDENCE IN SUPPORT OF CIRCADIAN VARIATION IN ACTH SECRETION.

Authors:  M M MARTIN; D E HELLMAN
Journal:  J Clin Endocrinol Metab       Date:  1964-03       Impact factor: 5.958

Review 4.  ACTINOMYCIN AND ITS EFFECTS; INFLUENCE ON AN EFFECTOR PATHWAY FOR HORMONAL CONTROL.

Authors:  L D SAMUELS
Journal:  N Engl J Med       Date:  1964-12-10       Impact factor: 91.245

5.  DIURNAL VARIATION IN SUPPRESSION OF ADRENAL FUNCTION BY GLUCOCORTICOIDS.

Authors:  T NICHOLS; C A NUGENT; F H TYLER
Journal:  J Clin Endocrinol Metab       Date:  1965-03       Impact factor: 5.958

6.  GLUCOCORTICOID TOXICITY: SINGLE CONTRASTED WITH DIVIDED DAILY DOSES OF PREDNISOLONE.

Authors:  C A NUGENT; J WARD; W D MACDIARMID; J C MCCALL; J BAUKOL; F H TYLER
Journal:  J Chronic Dis       Date:  1965-04

7.  Metabolism of hydrocortisone during inflammation.

Authors:  T F DOUGHERTY; H E BROWN; D L BERLINER
Journal:  Endocrinology       Date:  1958-04       Impact factor: 4.736

8.  Pharmacophysiologic principles in the use of corticoids and adrenocorticotropin.

Authors:  V C DIRAIMONDO; P H FORSHAM
Journal:  Metabolism       Date:  1958-01       Impact factor: 8.694

9.  The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

Authors:  R H SILBER; C C PORTER
Journal:  J Biol Chem       Date:  1954-10       Impact factor: 5.157

  9 in total
  6 in total

1.  Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects.

Authors:  W A McAllister; D M Mitchell; J V Collins
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

Review 2.  Circadian changes of drug disposition in man.

Authors:  A Reinberg; M H Smolensky
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

Review 3.  New aspects of human chronopharmacology.

Authors:  A Reinberg
Journal:  Arch Toxicol       Date:  1976-12-17       Impact factor: 5.153

4.  Alterations in prednisolone disposition as a result of time of administration, gender and dose.

Authors:  P J Meffin; P M Brooks; B C Sallustio
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

5.  Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.

Authors:  L E Fisher; E A Ludwig; J A Wald; R R Sloan; E Middleton; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1992-06       Impact factor: 6.875

6.  Time of day of prednisolone administration in rheumatoid arthritis.

Authors:  I C Kowanko; R Pownall; M S Knapp; A J Swannell; P G Mahoney
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.